We found that CK‐18, miR‐122 and miR‐192 performed as well or better than the commonly measured liver enzyme ALT at discriminating cases of MASLD and liver fibrosis, but recognise the need to replicate these findings in a larger cohort that includes more cases with advanced fibrosis. The gene discussed is KRT18; the disease is Hepatic fibrosis.